Related Experiment Video
Updated: Feb 9, 2026

Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines
Published on: November 8, 2011
Successful Treatment of Pediatric Epstein-Barr Virus-positive Aggressive Natural Killer-Cell Leukemia
Bo Kyung Kim1, Kyung Taek Hong1, Hyoung Jin Kang1
1Department of Pediatrics, Seoul National University College of Medicine, Seoul National University Cancer Research Institute.
Abstract:
Epstein-Barr virus (EBV)-positive aggressive natural killer-cell leukemia (ANKL) is a rare malignancy of mature natural killer cells, with a very poor survival rate. Patients have a rapidly declining clinical course and a poor prognosis, with a median survival of only a few months. Herein, we describe a 16-year-old boy who was diagnosed with EBV-positive ANKL and successfully treated using combination chemotherapy and a subsequent allogeneic hematopoietic stem cell transplantation (alloHSCT). The patient is disease free 4 years and 9 months after alloHSCT. Thus, combination chemotherapy followed by alloHSCT seems to be a promising therapeutic option for EBV-positive ANKL.
Related Concept Videos
Aggression
Ecological Succession
What are Viruses?
What is Natural Selection?
Nature and Nurture
Position-effect Variegation

